Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Survivin inhibitors

Survivin inhibitors

US Patent 7910742 · Granted Mar 22, 2011

Estimated economic value: $26,839,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Apoptosis inducing agents for the treatment of cancer and immune and autoimmune 2024
Apoptosis inducing agents for the treatment of cancer and immune and autoimmune 2024
Apoptosis inducing agents for the treatment of cancer and immune and autoimmune 2024
Synthesis of novel ketone body analogs for use as a nutritional supplement2023
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune 2023
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune 2023
Macrocyclic MCL-1 inhibitors and methods of use2020
Macrocyclic MCL-1 inhibitors and methods of use2020
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune 2018
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune 2018
Apoptosis-induced agents for the treatment of cancer and immune and autoimmune d2018
Apoptosis-induced agents for the treatment of cancer and immune and autoimmune d2018